Houston

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Pulmonary arterial hypertension2 trials
• Depression1 trial
• Fibromyalgia1 trial
• Insomnia1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Recruiting4 trials
• Active, not recruiting1 trial

Lead sponsor

• Axsome Therapeutics, Inc.3 trials
• Pulmovant, Inc.2 trials

Running trials

• Recruiting

  Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  NCT07484217· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

• Recruiting

  Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

  NCT07398417· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

• Recruiting

  A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  NCT07333183· Phase 2· Pulmovant, Inc.· Source

  Contact: Clinical Site

• Active, not recruiting

  A Study of Mosliciguat in PH-ILD

  NCT06635850· Phase 2· Pulmovant, Inc.· Source

• Recruiting

  Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

  NCT06568367· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression1 recruiting
• Fibromyalgia1 recruiting
• High blood pressure1 recruiting
• Insomnia1 recruiting
• Pulmonary arterial hypertension1 recruiting